GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (XSWX:GALD) » Definitions » Other Gross PPE

Galderma Group AG (XSWX:GALD) Other Gross PPE : CHF22 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Other Gross PPE?

Galderma Group AG's Other Gross PPE for the quarter that ended in Dec. 2024 was CHF22 Mil.

Galderma Group AG's quarterly Other Gross PPE increased from Dec. 2023 (CHF15 Mil) to Jun. 2024 (CHF21 Mil) and increased from Jun. 2024 (CHF21 Mil) to Dec. 2024 (CHF22 Mil).

Galderma Group AG's annual Other Gross PPE increased from . 20 (CHF0 Mil) to Dec. 2023 (CHF15 Mil) and increased from Dec. 2023 (CHF15 Mil) to Dec. 2024 (CHF22 Mil).


Galderma Group AG Other Gross PPE Historical Data

The historical data trend for Galderma Group AG's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Other Gross PPE Chart

Galderma Group AG Annual Data
Trend Dec23 Dec24
Other Gross PPE
14.70 22.29

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24
Other Gross PPE - 14.70 20.56 22.29

Galderma Group AG Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Galderma Group AG Business Description

Traded in Other Exchanges
Address
Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines